• Cyclic Pifithrin-α Hydrobromide: Precision p53 Inhibitor Wor

  2026-05-25

  Cyclic Pifithrin-α hydrobromide from APExBIO sets a new benchmark for p53 pathway dissection, enabling reproducible modulation of apoptosis and DNA damage responses in both cancer and neuroinflammation models. Its robust inhibition profile and radioprotective properties empower researchers to fine-tune experimental outcomes and minimize confounding side effects in preclinical studies.

• Structural Insights into Gepotidacin and DNA Gyrase Inhibiti

  2026-05-24

  This article examines a pivotal study that elucidates the mechanistic and structural basis for gepotidacin action against Staphylococcus aureus DNA gyrase. The research reveals how gepotidacin uniquely stabilizes single-stranded DNA breaks, contrasting traditional fluoroquinolones, and offers new directions for antibiotic resistance research.

• Adipose-Neural Axis Drives Cardiac Arrhythmias via Leptin-NP

  2026-05-23

  Fan et al. reveal that the interplay between epicardial adipose tissue and sympathetic neurons, mediated by leptin and neuropeptide Y (NPY), plays a critical role in triggering cardiac arrhythmias. This mechanistic insight highlights new targets for arrhythmia intervention and advances our understanding of neuro-cardiac signaling.

• Bazedoxifene in Postmenopausal Osteoporosis: Long-Term Effic

  2026-05-22

  The 2019 review by Yavropoulou et al. synthesizes seven years of clinical trial data on Bazedoxifene, a third-generation selective estrogen receptor modulator (SERM) for postmenopausal osteoporosis. The study highlights Bazedoxifene’s capacity to modestly enhance lumbar spine bone mineral density and reduce vertebral fracture risk, with a favorable safety profile for extended use.

• Diphenyleneiodonium Chloride: Precision in Redox and cAMP As

  2026-05-22

  Diphenyleneiodonium chloride (DPI) is a dual-function research tool that enables precise modulation of redox enzyme activity and cAMP signaling. Its unique profile as both an irreversible enzyme inhibitor and a GPR3 agonist unlocks advanced experimental workflows and troubleshooting strategies for oxidative stress and signaling studies.

• Proteoform-Specific Drug Targeting in Native Signaling Envir

  2026-05-21

  This study pioneers direct characterization of proteoform-specific interactions in native membrane environments, enabling unprecedented insights into how post-translational modifications shape drug binding and signaling. Findings highlight the complexity of off-target effects for PDE5 inhibitors like Vardenafil, emphasizing the need for proteoform-resolved approaches in drug discovery.

• PBS Liposomes: Reliable Controls for Macrophage Depletion As

  2026-05-21

  This article addresses common laboratory challenges in cell viability and macrophage depletion studies, demonstrating how PBS Liposomes (SKU K2722) from APExBIO serve as robust, reproducible, and biologically inert controls. Scenario-driven analysis highlights evidence-backed use cases, protocol parameters, and practical vendor considerations for researchers seeking reliable phosphate-buffered saline liposomes.

• DiscoveryProbe™ Metabolism-related Compound Library: Technic

  2026-05-20

  The DiscoveryProbe™ Metabolism-related Compound Library provides 493 pre-dissolved, cell-permeable small molecules for robust metabolic pathway research, enzyme inhibition assays, and metabolic disease investigation. It is optimized for in vitro and ex vivo use and not intended for diagnostic or therapeutic applications.

• IGFBP2-THBS1 Axis in GH-Driven Bone Growth for ISS Children

  2026-05-20

  This study elucidates a novel mechanism by which recombinant human growth hormone (GH) promotes bone growth in idiopathic short stature (ISS) children, identifying IGFBP2-mediated inhibition of THBS1 as a critical activator of the IGF-1 pathway in chondrocytes. These findings offer new molecular targets for optimizing GH therapy and improving outcomes in growth disorders.

• TaqI Restriction Endonuclease: Fast, Reliable DNA Digestion

  2026-05-19

  TaqI Restriction Endonuclease (SKU K3053) offers rapid, sequence-specific cleavage of plasmid, PCR, or genomic DNA, streamlining molecular cloning and analysis workflows. It is best suited for laboratory research applications demanding quick and efficient DNA digestion, but should not be used for diagnostic or medical purposes.

• 5-hme-dCTP: Precision in Plant Epigenetic DNA Modification R

  2026-05-19

  Unleash new dimensions in plant and environmental epigenetics with 5-hme-dCTP—engineered for high-fidelity DNA hydroxymethylation assays. This article delivers actionable workflows, troubleshooting, and protocol mastery, leveraging APExBIO's high-purity solution for next-level gene regulation studies.

• MEK1/2 and c-Myc:MAX Modulate PRC2-Mediated TERT Repression

  2026-05-18

  This study reveals how MEK1/2 kinases and the c-Myc:MAX complex prevent polycomb repressive complex 2 (PRC2)-mediated silencing of TERT in human pluripotent stem cells. The findings provide mechanistic insights into the epigenetic regulation of telomerase, with implications for stem cell maintenance and disease modeling.

• Vincristine Sulfate Workflows for Translational Cancer Resea

  2026-05-18

  Vincristine sulfate from APExBIO enables robust, reproducible disruption of microtubule dynamics in experimental oncology. This article delivers actionable protocols, advanced workflow enhancements, and troubleshooting insights for researchers targeting leukemia, lymphoma, and solid tumors.

• FXR-KLF11 Axis Suppresses JAK2/STAT3 to Protect Against CI-A

  2026-05-17

  This study uncovers a protective mechanism in contrast-induced acute kidney injury (CI-AKI) whereby FXR activation upregulates KLF11, which in turn suppresses the JAK2/STAT3 inflammatory pathway. These findings identify the FXR-KLF11 axis as a promising therapeutic target for preventing CI-AKI and advancing inflammation research.

• Resiniferatoxin (RTX): Protocols and Innovations in TRPV1 Re

  2026-05-16

  Resiniferatoxin (RTX) empowers pain and inflammation research with unmatched selectivity for TRPV1-positive neurons, enabling both in vivo and in vitro experimental precision. Learn how modern workflows leverage RTX’s ultra-potency to model, modulate, and dissect sensory neuron activity, with troubleshooting strategies for reproducibility and translational relevance.

451 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page